Document Page: First | Prev | Next | All | Image | This Release | Search

File: 120396_sep96_decls31_0001.txt
Page: 0001
Total Pages: 7

Subject: RECOMMENDATIONS OF THE AD HOC WORKING GROUP                     

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: RECOMMENDATIONS OF THE AD HOC GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE          

Document Number:          1

Folder SEQ  #:        175




                                     %JLUIIL I UNCLASSIFIED
                                DEPARTMENT OF THE ARMY
                                OFFICE OF THE SURGEON GENERAL
                                    S109 LEESBURG PIKE
                                 FALLS CHURCH, VA 22041-3258
                @y m
                AMMTMN OF

            SGPS-PSP                                   24 Aug 90


            MEMORANDUM FOR LIEUTENANT GENERAL     K F. LEDFORD

            SUBJECT: Recommendations of the AD HOC Working Group for the
            Medical Defense Against Biological Warfare


            1. On 20 and 24 August 1990, the Ad Hoc Working Group for the
            Medical Defense Against Biological Warfare formulated the
            following recommendations.

                a. Full scale production of the Anthrax vaccine (FDA
            approved) should be initiated. Immediately utilizing existing
            stocks of Anthrax vaccine, as manv troops as possible should
            r a c a i v a I &XI] &Kw l@         As additional stocks become
            available, personnel anould receive                The CENTCON
            Commander should determine which troops will receive the
            vaccine first.

                b. The production of the pentavalent toxoid (under IND)
            for botulism should also be increased. The limited "on-hand"
            stocks should be used for selected individuals and used under
            its existing IND guidelines. in addition, anti-toxins and a
            toxoid containing "F" should be made available as quickly as
            possible.

                c. Personnel and equipment should be placed in the theater
            of operation and at the 10th Medical Lab, Germany, with the
            capability of rapid diagnosis of BW agents and endemic disease
            in clinically ill personnel. These teams would also train
            on-site personnel. USAMRDC has agreed to perform this mission.
biotic chemoprophylaxis should
            not be routinely used. If a BW threat is imminent,
            doxycyclins, twice a day, should be given to selected
            individuals. This therapy should be continued for at least 20
            days and continued until at least all individuals receive two
            doses of the Anthrax vaccine.

                a. That CRDEC develop the capability for a rapid detection
            system for BW attack.

            2. USAMRDC personnel will speak with the manufacturer of the
            Anthrax vaccine and the pentavalent toxoid on 27 August 1990
            about expanding their production capabilities. In addition, on
            28 August 1990, USAMRDC personnel will be speaking with FDA
            representatives about using these products prior to the
            completion of FDA testing requirements.


    DECLASSIFIED                                UNCLASSIFIED
    ON: 01 NOV 96
    BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 7 f:/Week-36/BX003203/RECOMMENDATIONS OF THE AD HOC GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE/recommendations of the ad hoc working group:11089615091832
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = RECOMMENDATIONS OF THE AD HOC GROUP FOR THE MEDICAL DEFENSE AGAINST BIOLOGICAL WARFARE
Folder Seq # = 175
Subject = RECOMMENDATIONS OF THE AD HOC WORKING GROUP
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996